Medindia

X

For the Treatment of Moderate to Severe Alzheimer's Disease, a Combination Treatment That Delays Nursing Home Admission Would Earn Higher Patient Share in the U.S. Than Europe

Wednesday, February 17, 2010 General News J E 4
Advertisement
The Dimebon Plus Aricept Combination Will Become Decision Resources' Proprietary Clinical Gold Standard for the Treatment of Moderate to Severe Alzheimer's Disease in 2013

For more information, contact:

Gisselle Morales

Elizabeth Marshall

Decision Resources

Decision Resources, Inc.

781-296-2691

781-296-2563

gmorales@dresources.com

emarshall@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Improved Treatment Compliance With Medical Home Co...
S
New Management Reports From AdvancedMD Enables Bil...